ASX Announcements

Every company announcement lodged with the ASX — browse the selected trading day or search the historical archive.

ILAISLAND PHARMACEUTICALS LIMITED

Search keywords from ASX announcement titles across the ASX announcement archive.

All dates

ISLAND PHARMACEUTICALS LIMITED (ASX: ILA)

96 announcements

Date / TimeTitleType
21 Aug 2026, 18:56Island boosts Galidesivir supply as Ebola surgesCompany Update
13 Aug 2026, 19:21Date of AGM & Closing Date for Director NominationsMeetings & Governance
12 Aug 2026, 19:35Cleansing NoticeSecurities Administration
12 Aug 2026, 19:32Application for quotation of securities - ILAOther
7 Aug 2026, 18:43Investor presentationPresentations
30 July 2026, 19:47Quarterly Appendix 4C and Activities ReportQuarterly Reports
27 July 2026, 19:23Investor Presentation - TechKnow Invest RoadshowPresentations
14 July 2026, 02:29Notification regarding unquoted securities - ILAOther
14 July 2026, 02:27Notification regarding unquoted securities - ILAOther
14 July 2026, 02:21Notification regarding unquoted securities - ILAOther
14 July 2026, 02:21Notification regarding unquoted securities - ILAOther
13 July 2026, 19:46Texas Biomed SOW accelerates pivotal FDA pathwayCompany Update
8 July 2026, 20:02Investor Presentation - Ebola Clinical ProgramPresentations
8 July 2026, 19:00Notification of cessation of securities - ILAOther
7 July 2026, 19:02Galidesivir approved for treatment use in in Ebola epidemicCompany Update
3 July 2026, 22:23Trading HaltTrading Halt / Suspension
3 July 2026, 22:01Pause in TradingTrading Halt / Suspension
2 July 2026, 19:38Singapore Patent Expands Island's ISLA 101 Viral ProtectionCompany Update
17 June 2026, 18:54FDA Grants Orphan Designation for Galidesivir in MarburgCompany Update
16 June 2026, 19:58Investor Presentation - Asia Dengue SummitPresentations
11 June 2026, 22:25Investor presentation (updated)Presentations
11 June 2026, 19:46Investor presentationPresentations
10 June 2026, 18:53Island Secures USAMRIID Support for Galidesivir StudyCompany Update
4 June 2026, 19:03Island Advances Galidesivir GMP Manufacturing for BiodefenceCompany Update
21 May 2026, 19:25Island Adds Biodefence Leader as Filovirus Risks EscalateCompany Administration
19 May 2026, 18:44Island Bolsters US Biodefence Readiness Ahead of TrialsCompany Update
28 Apr 2026, 18:30Cleansing NoticeSecurities Administration
28 Apr 2026, 18:23Application for quotation of securities - ILAOther
27 Apr 2026, 19:46Quarterly Appendix 4C and Activities ReportQuarterly Reports
30 Mar 2026, 22:19Cleansing NoticeSecurities Administration
30 Mar 2026, 22:17Application for quotation of securities - ILAOther
23 Mar 2026, 21:29Cleansing NoticeSecurities Administration
23 Mar 2026, 21:27Application for quotation of securities - ILAOther
9 Mar 2026, 20:47Antiviral pipeline expansion through strategic collaborationCompany Update
4 Mar 2026, 20:22US Government collaboration for Galidesivir developmentCompany Update
2 Mar 2026, 20:37Trading HaltTrading Halt / Suspension
26 Feb 2026, 03:21Appendix 4D & Half-Year Financial StatementsFinancial Results
16 Feb 2026, 19:28Cleansing NoticeSecurities Administration
16 Feb 2026, 19:21Application for quotation of securities - ILAOther
10 Feb 2026, 21:45Response to ASX Query LetterASX Query
5 Feb 2026, 20:57Investor presentationPresentations
4 Feb 2026, 20:34Proposed issue of securities - ILASecurities Administration
4 Feb 2026, 20:34$9m placement to advance US biodefence opportunityCapital Raising
4 Feb 2026, 20:29FDA confirms Galidesivir approval pathwayCompany Update
2 Feb 2026, 19:43Trading HaltTrading Halt / Suspension
27 Jan 2026, 19:33Investor PresentationPresentations
27 Jan 2026, 19:32Quarterly Appendix 4C and Activities ReportQuarterly Reports
7 Jan 2026, 20:44US Patent Granted for Galidesivir in filoviridae virusesCompany Update
6 Jan 2026, 20:40Notification regarding unquoted securities - ILAOther
5 Jan 2026, 19:41Ongoing engagement with the US FDACompany Update
1–50 of 96
1 / 2

Bold Investors provides factual coverage of ASX company announcements and is not affiliated with, or endorsed by, ASX Limited. Nothing on this page is financial advice.